LONDON, May 25 (Reuters) - European regulators confirmed on
Friday that Roche's blockbuster cancer drug MabThera,
also known as Rituxan, was safe to use, following a
contamination scare at a factory in the United States.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment